Mandatory Industry Norms
Expected: ImmediateHIGH confidence
What: Retail GWP Growth: 33.6%
“The recent landmark GST exemption on retail health has been a structural catalyst lowering the all-in insurance cost for households.”
Star Health & Allied Insurance Company Ltd: Why Is It Outperforming Nifty 500?
ActiveRS +14.7%Weak10w Streak
In , Star Health & Allied Insurance Company Ltd (Finance - Non Life Insurance) is outperforming Nifty 500 with +14.7% relative strength. Fundamentals: Weak. On a 10-week streak.
Star Health & Allied Insurance Company Ltd Key Facts
- PE Ratio
- 55.0x
- Market Cap
- ₹30,606 Cr
- PAT Growth YoY
- +11000%
- Revenue Growth YoY
- +14%
- RS vs Nifty 500
- +14.7%
PB: Cycle BottomFalling Knife
What's Happening
🔻Earnings declining and PB falling — fundamentals deteriorating
🌐FII stake decreased 4.1% this quarter
🏛️DII accumulation — stake up 4.0%
💰Trading 88% above estimated fair value — significant premium
Earnings Acceleration Triggers
1. Mandatory Industry Norms
ImmediateHIGH
2. Value Added Product Mix Shift
CurrentHIGH
3. Operating Leverage Inflection
Q3MEDIUM
Key Risks
1. Potential regulatory review of commission structures and expenses of management
MEDIUM2. One-time impact of ₹16
LOW3. Not Given
LOWSector-Specific Signals
Combined Ratio98.9%-320 bps
Retail Loss Ratio68.4%-103 bps
Investment Yield (9M)9.6%
Solvency Ratio2.15x
Key Numbers
PAT Growth YoY
+11000%
Inflection Up
Revenue YoY
+14%
Stable
Price to Book
3.2
Current Price
₹520
Fundamental Score
33/100
Weak
3Y PAT CAGR
-3%
Market Cap
30.6K Cr
Valuation
Significantly Overvalued12-Week Performance
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
12 weeks agoThis week
Why Are Star Health & Allied Insurance Company Ltd's Earnings Accelerating?
Based on Q3 FY26 earnings • Updated Apr 18, 2026
Value Added Product Mix Shift
Expected: CurrentHIGH confidence
What: Long-term Policy GWP: 51% of fresh GWP
“In terms of GWP, it is at 51% versus 34% on nine-month basis... long-term policies also improve our capital efficiency.”
Operating Leverage Inflection
Expected: Q3MEDIUM confidence
What: Expense Ratio: 30.1%
Impact: 16 bps improvement
“Our expense ratio declined further by 16 basis points from 30.3% in the last year to 30.1% in Q3 FY2026.”
Tam Expansion Changing Consumption
Expected: OngoingLOW confidence
What: Telemedicine Growth: 73%
“Expansion of doctors and specialties has driven 73% growth in our telemedicine numbers, indicating strong adoption.”
Regulatory Approval Or License Win
Expected: FutureLOW confidence
What: Insurance Laws Bill 2025: Sabka Bima Sabki Raksha
“We welcome the recent “Sabka Bima Sabki Raksha” that is the amendment of the Insurance Laws Bill 2025.”
PAT of ₹449 Cr vs ₹87 Cr YoY
HIGH confidence
What: PAT of ₹449 Cr vs ₹87 Cr YoY
“IND AS PAT for the 3rd Quarter, increased from Rs. 87 crore for Q3 FY2025 to Rs. 449 crore for Q3 FY2026.”
Combined Ratio guidance raised
HIGH confidence
What: 102.1% (Q3 FY25) → 98.9% (Q3 FY26)
“This was driven by improvement in combined ratio by almost 320 basis points from 102.1% in Q3 FY2025 to 98.9% in Q3 FY2026.”
What Are the Key Risks for Star Health & Allied Insurance Company Ltd?
Earnings deceleration risks from management commentary
Potential regulatory review of commission structures and expenses of management
MEDIUMTrigger: The regulator may be reviewing industry-wide expense caps to protect consumer interests.
Management view: Management stated they will be prepared for any articulated reductions and are already passing on GST benefits.
Monitor: regulatory
One-time impact of ₹16
LOWTrigger: Implementation of new labor code requirements affecting operating expenses.
Impact: PAT impact: ₹16.5 Cr
Management view: Reported as a one-time impact in Opex for the quarter.
Monitor: labor
Not Given
LOWTrigger: Not explained on call
Monitor: fx
What Is Star Health & Allied Insurance Company Ltd's Management Saying?
Key quotes from recent conference calls
“The retail loss ratio for H1 FY2026 stands at 69.9%... We expect this to improve further in the quarters ahead. [Previous Loss Ratio guidance]”
“As far as the cohort-based pricing approach that we took for FHO, that has given us very good results. [Initiative: FHO Cohort-based Pricing]”
“In quarter 3, our distribution app, which is ATOM, facilitated 85% of the fresh policy acquisitions. [Initiative: Digital Acquisition (ATOM App)]”
“We expect that the regulator may be reviewing this... expenses of management have to be adhered to. [Risk (regulatory): MEDIUM]”
What Did Star Health & Allied Insurance Company Ltd Report This Quarter?
Headline numbers from the latest earnings call
Revenue
₹5,047 Cr
YoY +23%
Why: Growth was driven by a 33.6% increase in retail health insurance, which is 3x the industry growth rate, following the GST exemption catalyst.
Retail health remains the primary growth engine, significantly outperforming the broader non-life insurance industry.
EBITDA
₹46 Cr
Why: The shift from an underwriting loss to profit was driven by a 320 basis point improvement in the combined ratio to 98.9%.
Underwriting profitability returned this quarter due to sustained improvements in loss and expense ratios.
PAT
₹449 Cr
YoY +416.1%
Why: Profit growth was fueled by both improved operating performance and a strong investment yield of 9.6% for the nine-month period.
The massive YoY jump in PAT reflects the combined impact of underwriting turnaround and high-yielding investment assets.
Other Highlights
• Retail loss ratio decreased by 103 basis points year-on-year to 68.4% in Q3.
• Expense ratio declined to 30.1% from 30.3% in the previous year.
• Investment yield reached 9.6% for 9M FY2026, supported by high-yielding assets.
What Sector Metrics Matter for Star Health & Allied Insurance Company Ltd?
Sub-sector-specific signals from the latest concall — each with management's stated reason for the change
Combined Ratio
98.9%
YoY -320 bps
Why: Driven by continuous loss ratio decline and expense ratio improvements.
Retail Loss Ratio
68.4%
YoY -103 bps
Why: Result of targeted underwriting, pricing, and associated corrective strategies.
Investment Yield (9M)
9.6%
Why: Supported by a diversified profile of assets including equities, ETFs, REITs, and InvITs.
Solvency Ratio
2.15x
Why: Maintained well above the regulatory requirements.
Expense Ratio
30.1%
YoY -20 bps
Why: Declined due to productivity gains and digital transformation efforts.
Claim Settlement Ratio
90%
YoY +500 bps
Why: Improved operational rigour and efficiencies in claim processing.
Persistency (Value-wise)
99.2%
Why: Robust consumer satisfaction and retention trends.
Retail Health Market Share
31.3%
Why: Maintained leadership despite heavy competition in the retail segment.
What Is Star Health & Allied Insurance Company Ltd's Management Guidance?
Forward-looking targets from management for Long-term
OPM Guidance
15%
Margin Outlook
Targeting mid-teens ROE through a blend of loss ratio and combined ratio management.
Volume
Expect 10% price hike for senior citizen products as guided by the regulator.
Management Tone: BULLISH
Guidance Changes
RAISED
Combined Ratio: 102.1% (Q3 FY25) → 98.9% (Q3 FY26)
How Fast Is Star Health & Allied Insurance Company Ltd Growing?
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +14% | +14% | Stable |
| PAT (Net Profit) | +11000% | -3% | Inflection Up |
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Apr 18, 2026.
Other Top Finance - Non Life Insurance Stocks Beating Nifty 500
Frequently Asked Questions: Star Health & Allied Insurance Company Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What were Star Health & Allied Insurance Company Ltd's latest quarterly results?
Star Health & Allied Insurance Company Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: +11000.0% (turning around (inflection up))
- Revenue Growth YoY: +13.9%
- Operating Margin: 3.0%
Is Star Health & Allied Insurance Company Ltd's profit growing or declining?
Star Health & Allied Insurance Company Ltd's profit is growing with an turning around (inflection up) trend.
- PAT Growth YoY: +11000.0% (latest quarter)
- PAT Growth QoQ: -13.3% (sequential)
- 3-Year PAT CAGR: -3.5%
- Trend: Turning around (inflection up) — consistent growth pattern
What is Star Health & Allied Insurance Company Ltd's revenue growth trend?
Star Health & Allied Insurance Company Ltd's revenue growth trend is stable.
- Revenue Growth YoY: +13.9%
- Revenue Growth QoQ: +1.8% (sequential)
- 3-Year Revenue CAGR: +13.8%
What is Star Health & Allied Insurance Company Ltd's asset quality trend?
Star Health & Allied Insurance Company Ltd's asset quality trend is insufficient_data.
What is Star Health & Allied Insurance Company Ltd's 3-year profit and revenue CAGR?
Star Health & Allied Insurance Company Ltd's long-term compounding rates
- 3-Year Profit CAGR: -3.5%
- 3-Year Revenue CAGR: +13.8%
Is Star Health & Allied Insurance Company Ltd's growth accelerating or decelerating?
Star Health & Allied Insurance Company Ltd's earnings growth is turning around (inflection up) with mixed signals on a sequential basis.
- YoY Acceleration: +140.5% bps
- Sequential Acceleration: -63.3% bps
What is Star Health & Allied Insurance Company Ltd's trailing twelve month (TTM) performance?
Star Health & Allied Insurance Company Ltd's trailing twelve month (TTM) performance
- TTM PAT: ₹557 Cr
- TTM PAT Growth: -13.8% YoY
- TTM Revenue: ₹18,000 Cr
- TTM Revenue Growth: +10.7% YoY
Is Star Health & Allied Insurance Company Ltd overvalued or undervalued?
Star Health & Allied Insurance Company Ltd appears significantly overvalued based on our fair value analysis.
- Valuation Signal: Significantly Overvalued
- Current PE: 55.0x
- Price-to-Book: 3.2x
What is Star Health & Allied Insurance Company Ltd's current PE ratio?
Star Health & Allied Insurance Company Ltd's current PE ratio is 55.0x.
- Current PE: 55.0x
- Market Cap: 30.6K Cr
How does Star Health & Allied Insurance Company Ltd's valuation compare to its history?
Star Health & Allied Insurance Company Ltd's current PE is 55.0x.
- Current PE: 55.0x
- Valuation Assessment: Significantly Overvalued
What is Star Health & Allied Insurance Company Ltd's price-to-book ratio?
Star Health & Allied Insurance Company Ltd's price-to-book ratio is 3.2x.
- Price-to-Book (P/B): 3.2x
- Book Value per Share: ₹163
- Current Price: ₹520
Is Star Health & Allied Insurance Company Ltd a fundamentally strong company?
Star Health & Allied Insurance Company Ltd is rated Weak with a fundamental score of 33/100. This score is calculated from objective financial metrics
- PAT Growth YoY: +11000.0% (20% weight)
- PAT Growth QoQ: -13.3% (15% weight)
- Earnings trend: inflection_up (5% weight)
Is Star Health & Allied Insurance Company Ltd debt free?
Star Health & Allied Insurance Company Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹490 Cr
What is Star Health & Allied Insurance Company Ltd's return on equity (ROE) and ROCE?
Star Health & Allied Insurance Company Ltd's return ratios over recent years
- FY2024: ROCE 18.0%
- FY2025: ROCE 12.0%
- FY2026: ROCE 9.0%
Is Star Health & Allied Insurance Company Ltd's cash flow positive?
Star Health & Allied Insurance Company Ltd's operating cash flow is positive (FY2025).
- Cash from Operations (CFO): ₹1,000 Cr
- Free Cash Flow (FCF): ₹228 Cr
- CFO/PAT Ratio: 213% (strong cash conversion)
What is Star Health & Allied Insurance Company Ltd's dividend yield?
Star Health & Allied Insurance Company Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹520
Who holds Star Health & Allied Insurance Company Ltd shares — promoters, FII, DII?
Star Health & Allied Insurance Company Ltd's shareholding pattern (Mar 2026)
- Promoters: 58.0%
- FII (Foreign): 15.1%
- DII (Domestic): 20.3%
- Public: 6.7%
Is promoter holding increasing or decreasing in Star Health & Allied Insurance Company Ltd?
Star Health & Allied Insurance Company Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 58.0% (Mar 2026)
- Previous Quarter: 58.0% (Dec 2025)
- Change: 0.00% (stable)
How long has Star Health & Allied Insurance Company Ltd been outperforming Nifty 500?
Star Health & Allied Insurance Company Ltd has been outperforming Nifty 500 for 10 consecutive weeks, indicating consistent outperformance.
Is Star Health & Allied Insurance Company Ltd a new momentum entry or an established outperformer?
Star Health & Allied Insurance Company Ltd is an established outperformer with 10 weeks of consecutive Nifty 500 outperformance.
What are the growth catalysts for Star Health & Allied Insurance Company Ltd?
Star Health & Allied Insurance Company Ltd has 7 key growth catalysts identified from recent earnings analysis
- Mandatory Industry Norms — The GST exemption on retail health has lowered costs for households, stimulating demand.
- Value Added Product Mix Shift — Long-term policies improve capital efficiency and lock in customers at better retention rates.
- Operating Leverage Inflection — Digitalization and automation are reducing the cost of acquisition and servicing.
- Tam Expansion Changing Consumption — Rising consumer intent and digital adoption are expanding the addressable market for wellness and home healthcare.
What are the key risks in Star Health & Allied Insurance Company Ltd?
Star Health & Allied Insurance Company Ltd has 3 key risks worth monitoring
- [MEDIUM] Potential regulatory review of commission structures and expenses of management — The regulator may be reviewing industry-wide expense caps to protect consumer interests.
- [LOW] One-time impact of ₹16 — Implementation of new labor code requirements affecting operating expenses.
- [LOW] Not Given
What did Star Health & Allied Insurance Company Ltd's management say in the latest earnings call?
In Q3 FY26, Star Health & Allied Insurance Company Ltd's management highlighted
- "The retail loss ratio for H1 FY2026 stands at 69.9%... We expect this to improve further in the quarters ahead. [Previous Loss Ratio guidance]"
- "As far as the cohort-based pricing approach that we took for FHO, that has given us very good results. [Initiative: FHO Cohort-based Pricing]"
- "In quarter 3, our distribution app, which is ATOM, facilitated 85% of the fresh policy acquisitions. [Initiative: Digital Acquisition (ATOM App)]"
What is Star Health & Allied Insurance Company Ltd's management guidance for growth?
Star Health & Allied Insurance Company Ltd's management has provided the following forward guidance for Long-term
- Revenue outlook: Not Given
- OPM guidance: 15%
- Capex plan: Not Given for Technology and digital infrastructure
- Management tone: bullish
- Milestone: [RAISED] Combined Ratio: 102.1% (Q3 FY25) → 98.9% (Q3 FY26)
What sector-specific metrics matter most for Star Health & Allied Insurance Company Ltd?
Star Health & Allied Insurance Company Ltd's most important sub-sector-specific KPIs from the latest concall
- Combined Ratio: 98.9% (YoY -320 bps) — Driven by continuous loss ratio decline and expense ratio improvements.
- Retail Loss Ratio: 68.4% (YoY -103 bps) — Result of targeted underwriting, pricing, and associated corrective strategies.
- Investment Yield (9M): 9.6% — Supported by a diversified profile of assets including equities, ETFs, REITs, and InvITs.
- Solvency Ratio: 2.15x — Maintained well above the regulatory requirements.
- Expense Ratio: 30.1% (YoY -20 bps) — Declined due to productivity gains and digital transformation efforts.
- Claim Settlement Ratio: 90% (YoY +500 bps) — Improved operational rigour and efficiencies in claim processing.
Is Star Health & Allied Insurance Company Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Star Health & Allied Insurance Company Ltd may be worth studying
- Earnings growing at +11000.0% YoY
- Cash flow is positive — CFO ₹1,000 Cr
What is the investment thesis for Star Health & Allied Insurance Company Ltd?
Star Health & Allied Insurance Company Ltd investment thesis summary:
Research Signals (Bull Case)
- Revenue growing at +13.9% YoY
- Growth catalyst: Mandatory Industry Norms
Risk Factors (Bear Case)
- Appears significantly overvalued
- Key risk: Potential regulatory review of commission structures and expenses of management
What is the future outlook for Star Health & Allied Insurance Company Ltd?
Star Health & Allied Insurance Company Ltd's forward outlook based on current data signals
- Earnings Trend: turning around (inflection up)
- Revenue Trend: stable
- Valuation: Significantly Overvalued
- Key Catalyst: Mandatory Industry Norms
- Key Risk: Potential regulatory review of commission structures and expenses of management
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.